Companies
Edwards Lifesciences
S&P 500Health Care· USA

EW

Status-Quo-Player

Edwards Lifesciences

$78.12

+0.33%

Open $77.57·Prev $77.86

as of 13 Apr

STATUS-QUO-PLAYER

Power Core

The moat is a compounding clinical evidence base that took fifteen years to build, cannot be fast-tracked, and anchors physician behavior at the point of care.

Published1 Apr 2026
UniverseS&P 500
SectorHealth Care

Direction of Movement

Transitioning From TAVR Dominance to Multi-Valve Platform

ROC 200

+8.3%

This page is for informational purposes only and does not constitute investment advice. L17X Research is an independent research service.
EW — Edwards Lifesciences — Power Mapping Analysis — L17X — L17X